Illumina
Contact Me 
Sanger Sequencing vs Illumina NGS

If you're spending too much time and money identifying variants through Sanger sequencing or qPCR, download our guide to learn how targeted NGS can help you determine variants in less time and for less money.

 

Topics include

  • Why now is the time to consider targeted NGS?
  • When does targeted resequencing make the most sense?
  • Benefits of targeted resequencing vs qPCR and Sanger Sequencing
  • Introduction to Illumina targeted NGS solutions
Company Legal
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.